Feng Chen

发表

Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia

Quanfu Li, G. Jin, Zewei Zhang, 2021, Archives of medical science : AMS.

A Comparison of the Efficacy of 5 mg Olanzapine and Aprepitant in the Prevention of Multiple-Day Cisplatin Chemotherapy-Induced Nausea and Vomiting

Yilan Jin, G. Jin, Zewei Zhang, 2022, International journal of clinical practice.

Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV

Min Gu, Yilan Jin, Jun Zhao, 2021, Pharmacogenomics and personalized medicine.

Effectiveness and safety of combined neurokinin-1 antagonist aprepitant treatment for multiple-day anthracycline-induced nausea and vomiting.

Jun Zhao, Xiaojun Bai, Quanfu Li, 2019, Current problems in cancer.

Evaluation of a Neurokinin-1 Antagonist in Preventing Multiple-day Cisplatin-induced Nausea and Vomiting

Jun Zhao, Xiaojun Bai, Quanfu Li, 2018, Open medicine.

Treatment and survival status of patients with EGFR mutation-positive stage IV lung adenocarcinoma: five-year follow-up results in the Ordos Area of Inner Mongolia, China

Jun Zhao, Xiaojun Bai, G. Jin, 2018, Oncology and Translational Medicine.

Mitochondrial energy metabolism correlates with an immunosuppressive tumor microenvironment and poor prognosis in esophageal squamous cell carcinoma

Lei Zhao, G. Wuyun, G. Jin, 2023, Computational and structural biotechnology journal.

F-box and leucine-rich repeat protein 16 controls tamoxifen sensitivity via regulation of mitochondrial respiration in estrogen receptor-positive breast cancer cells.

Rui Gao, Yao Song, Yanhan Jia, 2023, Human cell.

A randomized trial evaluating the association between related gene polymorphism and nausea and vomiting induced by cisplatin multi-day chemotherapy

G. Jin, Zewei Zhang, Juan Zhao, 2023, BMC Medical Genomics.

A prospective randomized controlled clinical trial investigating the efficacy of low-dose olanzapine in preventing nausea and vomiting associated with oxaliplatin-based and irinotecan-based chemotherapy

G. Jin, Wenjuan Wang, Juan Zhao, 2024, Journal of cancer research and clinical oncology.

Olanzapine (5 mg) plus standard triple antiemetic therapy for the prevention of multiple-day cisplatin hemotherapy-induced nausea and vomiting: a prospective randomized controlled study

Yilan Jin, Jun Zhao, Quanfu Li, 2022, Supportive Care in Cancer.